Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Texas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Texas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Texas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Richard Lane (NPI 1922086347)

Field	Value
Entity Type	Individual
Organization	Richard Lane
Address	9480 Huebner Rd Ste 310
City	San Antonio
State	TX
ZIP	78240
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	January 5, 2006

Payer Source	Total Paid
Medicare	$4.8M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the public program mix: total Medicare revenue is $4.8M and there is no Medicaid billing on file. The absence of Medicaid activity indicates Medicare patients drive the entire observed public‑payer business for this SAN ANTONIO retina specialist.

Revenue is highly concentrated in a small number of intravitreal drug codes: the precomputed top 3 Medicare codes by revenue account for 78.4% of this provider's total Medicare revenue, with J0178 alone representing $2.7M (55.5% of Medicare revenue). That concentration signals material dependence on a few high‑revenue ophthalmic pharmaceuticals for practice financials.

The procedural and clinical mix is characteristic of a retina practice built around anti‑VEGF and related intravitreal therapy plus diagnostic retina imaging. The top billed items are J0178 ($2.7M), J2777 ($774.4K) and Q5128 ($327.9K), and the high volume of 92134 (3.1K claims, $88.7K revenue) shows frequent retinal OCT imaging and interpretation supporting injection‑based care.

National competitive standing shows above‑typical scale on key retina service lines: J0178 ranks #79 of 3204 providers nationally (98th percentile; notably above typical national volume for this code), indicating this provider is a high‑volume aflibercept injector relative to peers. Likewise, 92134 ranks #379 of 26868 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code), which points to unusually high use of retinal imaging workflows.

Several high‑revenue drugs appear as modest contributors by share but have high per‑claim payments, suggesting selective use of non‑standard or unclassified agents. J3490 ($138K, 73 claims, $1890 avg paid/claim) and J3590 ($122.7K, 66 claims, $1859 avg paid/claim) together account for a small portion of revenue (2.9% and 2.6% respectively) but show large average payments per administration. These items are supplemental to the main anti‑VEGF volume rather than primary revenue drivers.

Other intravitreal and related procedure codes show mixed national positioning: J2777 (26.7K claims, $774.4K revenue) is ranked #350 of 2039 providers nationally (83th percentile; typical, unremarkable volume for this code) and Q5128 (1.5K claims, $327.9K revenue) ranks #87 of 373 providers nationally (77th percentile; typical, unremarkable volume for this code). This pattern implies strong aflibercept activity coupled with more typical peer‑level use of faricimab and ranibizumab biosimilar products.

Surgical retina and other operative procedures contribute only modestly to Medicare revenue, consistent with an outpatient injection‑focused practice rather than a surgical retina center. Examples include 67041 ($15.9K), 67036 ($12.6K) and 67121 ($12.8K), each accounting for a small share of total Medicare revenue and ranking at middling national positions. These figures point to occasional surgical work but not a primary revenue stream.

The provider has long tenure in the NPI registry (NPI enumerated 2006-01-05, ~20 years ago), which—combined with concentrated, high‑volume anti‑VEGF and retinal imaging billing—supports the view of an established retina specialist practice in SAN ANTONIO that is operationally centered on frequent intravitreal injections and associated diagnostic imaging.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,870	$690	$2.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	26,710	$30	$774.4K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,510	$220	$327.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,440	$90	$224.5K
J3490	Unclassified drugs	70	$1,890	$138K
J3590	Unclassified biologics	70	$1,860	$122.7K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	900	$120	$108.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,060	$30	$88.7K
J2778	Injection, ranibizumab, 0.1 mg	400	$180	$72.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	800	$90	$70.4K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Texas Distribution

Richard Lane — 3 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Texas

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	7	210	610	$690	$694.9K
J2777	17	140	7,470	$30	$479.2K
J2778	55	80	630	$180	$345.3K
Q5128	14	50	770	$220	$263.7K
J3590	20	40	70	$1,640	$162.7K
J2781	20	50	720	$120	$131.9K
67028	20	290	510	$90	$73K
J3490	114	350	60	$480	$54.4K
J7312	5	40	200	$150	$40.8K
67036	30	70	20	$1,000	$29.1K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Richard Lane, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Samuel Jurca	ID	Family Medicine Physician	$24M	$0
Charles Wykoff	TX	Ophthalmology Physician	$6.2M	$0
Matthew Benz	TX	Ophthalmology Physician	$5.7M	$0
David Brown	TX	Ophthalmology Physician	$5.7M	$0
Tien Wong	TX	Ophthalmology Physician	$4.5M	$0
Thomas Oei	TX	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Ronald Drengler	TX	Medical Oncology Physician	$3.8M	$0
Jose Martinez	TX	Ophthalmology Physician	$3.8M	$0
Ankoor Shah	TX	Ophthalmology Physician	$3.7M	$0
Jeremiah Brown	TX	Retina Specialist (Ophthalmology) Physician	$3.7M	$0

Nearby Providers

Other providers in the same ZIP code as Richard Lane, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Aim Care Home Health Inc.	TX	In Home Supportive Care Agency	$0	$40.3M
Deer Oaks Geriatric Services P C	TX	Clinical Psychologist	$0	$17M
Lhcg Cxxiv, LLC	TX	In Home Supportive Care Agency	$0	$14M
Sarah Holy	TX	Retina Specialist (Ophthalmology) Physician	$3.5M	$0
Manjulatha Badam	TX	Undersea and Hyperbaric Medicine (Preventive Medicine) Physician	$2.9M	$0
Moises Chica	TX	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Calvin Mein	TX	Ophthalmology Physician	$2.5M	$0
Sridhar Beeram	TX	Hematology & Oncology Physician	$1.8M	$0
Lama Hashish	TX	Rheumatology Physician	$1.8M	$0
Michael Singer	TX	Ophthalmology Physician	$1.5M	$0

Richard Lane — Billing Profile & Reimbursement Data

Sign up for Richard Lane — Billing Profile & Reimbursement Data policy alerts

Richard Lane — Billing Profile & Reimbursement Data

Sign up for Richard Lane — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References